XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Collaboration Agreements, License Agreement and Revenues - Summary of License Revenue and Development Revenue Recognized under Agreement (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue $ 55,902 $ 36,161
License Revenue [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 0 6,000
Development Revenue [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 878 3,891
Astellas Agreement [Member] | License Revenue [Member] | Europe [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 287 1,529
AstraZeneca Agreements [Member] | Development Revenue [Member] | U.S./RoW and China [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue $ 468 $ 2,032